Bausch and Lomb has announced a planned first quarter acquisition of cataract repair company Eyeonics, Inc. Eyeonics is known for the cystalens intraocular lens, which has been used for the treatment of cataracts in more than 95,000 eyes worldwide. 

Eyeonics, a privately held company based in Aliso Viejo Cali., generated approximately $34 million in revenues in 2007.  The company will become a part of Bausch & Lomb’s surgical business under J. Andy Corley, eyeonics’ co-founder, chairman, and CEO.